In last trading session, Biohaven Ltd (NYSE:BHVN) saw 1.27 million shares changing hands with its beta currently measuring 3.87. Company’s recent per share price level of $36.00 trading at -$3.12 or -7.98% at ring of the bell on the day assigns it a market valuation of $3.64B. That closing price of BHVN’s stock is at a discount of -72.81% from its 52-week high price of $62.21 and is indicating a premium of 25.56% from its 52-week low price of $26.80. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.97 million shares which gives us an average trading volume of 1.05 million if we extend that period to 3-months.
For Biohaven Ltd (BHVN), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.13. Splitting up the data highlights that, out of 7 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 7 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Biohaven Ltd (NYSE:BHVN) trade information
Upright in the red during last session for losing -7.98%, in the last five days BHVN remained trading in the red while hitting it’s week-highest on Thursday, 12/12/24 when the stock touched $36.00 price level, adding 15.41% to its value on the day. Biohaven Ltd’s shares saw a change of -15.89% in year-to-date performance and have moved -15.87% in past 5-day. Biohaven Ltd (NYSE:BHVN) showed a performance of -20.72% in past 30-days. Number of shares sold short was 7.84 million shares which calculate 9.66 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 59 to the stock, which implies a rise of 38.98% to its current value. Analysts have been projecting 55 as a low price target for the stock while placing it at a high target of 65. It follows that stock’s current price would drop -52.78% in reaching the projected high whereas dropping to the targeted low would mean a loss of -52.78% for stock’s current value.
Biohaven Ltd (BHVN) estimates and forecasts
Statistics highlight that Biohaven Ltd is scoring comparatively lower than the scores of other players of the relevant industry. The company added 7.66% of value to its shares in past 6 months, showing an annual growth rate of -54.45% while that of industry is 17.30. Apart from that, the company came lowering its revenue forecast for fiscal year 2024.
Biohaven Ltd (NYSE:BHVN)’s Major holders
Insiders are in possession of 11.16% of company’s total shares while institution are holding 87.17 percent of that, with stock having share float percentage of 98.12%. Investors also watch the number of corporate investors in a company very closely, which is 87.17% institutions for Biohaven Ltd that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at BHVN for having 7.27 million shares of worth $252.41 million. And as of 2024-06-30, it was holding 8.9114 of the company’s outstanding shares.
The second largest institutional holder is STIFEL FINANCIAL CORP, which was holding about 6.48 million shares on 2024-06-30. The number of shares represents firm’s hold over 7.9417 of outstanding shares, having a total worth of $224.94 million.
